Nimotuzumab plus platinum-based chemotherapy versus platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma

Yunshu Zhu, Sheng Yang, Shengyu Zhou, Jianliang Yang, Yan Qin, Lin Gui, Yuankai Shi, Xiaohui HeTherapeutic 2020 · DOI

Abstract

Our findings suggested that NTZ+CT provides a novel treatment option and prolongs survival significantly for R/M-NPC.
BibTeX
@inproceedings{zhu2020nimotuzumab,
  author = {Yunshu Zhu and Sheng Yang and Shengyu Zhou and Jianliang Yang and Yan Qin and Lin Gui and Yuankai Shi and Xiaohui He},
  title = {{Nimotuzumab plus platinum-based chemotherapy <i>versus</i> platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma}},
  booktitle = {Therapeutic},
  year = {2020},
  doi = {10.1177/1758835920953738},
}

Loading related content...

Figure